Analysts expect Exscientia Ltd (NASDAQ:EXAI) to post earnings per share of ($0.12) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Exscientia’s earnings. The highest EPS estimate is ($0.05) and the lowest is ($0.19). The company is expected to announce its next earnings report on Wednesday, February 16th.
According to Zacks, analysts expect that Exscientia will report full-year earnings of ($0.50) per share for the current financial year, with EPS estimates ranging from ($0.63) to ($0.37). For the next fiscal year, analysts anticipate that the company will report earnings of ($0.58) per share, with EPS estimates ranging from ($0.60) to ($0.56). Zacks Investment Research’s earnings per share averages are an average based on a survey of analysts that cover Exscientia.
Exscientia (NASDAQ:EXAI) last posted its earnings results on Wednesday, November 17th. The company reported ($0.08) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.21) by $0.13. The firm had revenue of $24.33 million for the quarter.
EXAI opened at $18.80 on Wednesday. Exscientia has a fifty-two week low of $17.02 and a fifty-two week high of $30.38. The company has a debt-to-equity ratio of 0.02, a current ratio of 4.80 and a quick ratio of 4.80. The stock’s fifty day moving average price is $20.17.
Exscientia plc is an AI-driven pharmatech company. It involved in discovering, designing and developing drugs. Exscientia plc is based in OXFORD, England.
See Also: What is a SEC Filing?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Exscientia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exscientia and related companies with MarketBeat.com's FREE daily email newsletter.